Sugi Predict

Sugi Predict / Compounds / SCHEMBL1048050

SCHEMBL1048050

SCHEMBL1048050

O=c1[nH]ccc2cc(CCc3ccccc3)nc(Nc3cccc(C(F)(F)F)c3)c12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ZAP70 P43403 3/20 0.62
▸ LRRK2 Q5S007 1/20 0.50
▸ KDR P35968 2/20 0.48
▸ CTSC P53634 2/20 0.44
▸ IDH2 P48735 1/20 0.43
▸ ABCG2 Q9UNQ0 1/20 0.41
▸ EGFR P00533 1/20 0.41
▸ SLC2A1 P11166 1/20 0.40
▸ FER P16591 1/20 0.40
▸ RXFP1 Q9HBX9 2/20 0.40
▸ HTT P42858 2/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ GMNN O75496 1/20 0.39
▸ TTR P02766 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1044810 0.88 ZAP70 (0.72) ZAP70LRRK2KDREGFRFER
SCHEMBL1046978 0.86 ZAP70 (0.70) ZAP70LRRK2KDREGFRFER
SCHEMBL1083391 0.85 ZAP70 (0.69) ZAP70LRRK2KDRIDH2EGFR
SCHEMBL1045593 0.84 ZAP70 (0.63) ZAP70LRRK2CTSCIDH2ABCG2
SCHEMBL1049378 0.83 ZAP70 (0.63) ZAP70LRRK2IDH2EGFRFER
SCHEMBL1050028 0.81 ZAP70 (0.66) ZAP70LRRK2IDH2ABCG2FER
SCHEMBL1048085 0.78 ZAP70 (0.64) ZAP70FERJAK2
SCHEMBL12794742 0.78 ZAP70 (0.48) ZAP70FERJAK2
SCHEMBL12928852 0.77 ZAP70 (0.60) ZAP70LRRK2CTSCABCG2HTT
SCHEMBL12794764 0.77 ZAP70 (0.59) ZAP70FERJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8546370-B2 Compounds and compositions as kinase inhibitors IRM LLC (BM) 2013-10-01 — — US claimed
US-20110003798-A1 COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS IRM LLC (BM) 2011-01-06 — — US claimed
EP-2238137-A1 COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS IRM LLC (BM) 2010-10-13 — — EP claimed
WO-2009097287-A1 COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS IRM LLC (BM) 2009-08-06 — — WO claimed
US-8546370-B2 Compounds and compositions as kinase inhibitors IRM LLC (BM) 2013-10-01 — — US disclosed
US-8546370-B2 Compounds and compositions as kinase inhibitors IRM LLC (BM) 2013-10-01 — — US disclosed
US-8546370-B2 Compounds and compositions as kinase inhibitors IRM LLC (BM) 2013-10-01 — — US disclosed
US-20110003798-A1 COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS IRM LLC (BM) 2011-01-06 — — US disclosed
US-20110003798-A1 COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS IRM LLC (BM) 2011-01-06 — — US disclosed
US-20110003798-A1 COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS IRM LLC (BM) 2011-01-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110003798-A1 COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS FYN, SYK, RET ZAP70 4/4885LRRK2 517/4885KDR 18/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.